NANCY JOHNSON — Lobbyist Profile | Poliscope

NANCY JOHNSON

Reported covered position: FRM. MEMB. HOUSE OF REP/LOBBY EXEC. BR.ONLY

Filings

507

Clients

Firms

Years active

2007–2019

Associated filing income

$8,610,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
ARRIVA MEDICAL	33	2010–2017
DIABETES MANAGEMENT & SUPPLIES	31	2012–2019
MEDENVIOS HEALTHCARE	30	2010–2019
UNITED STATES MEDICAL SUPPLY	29	2010–2017
ST LUKE'S EPISCOPAL HEALTH SYSTEM	28	2008–2014
ADVANCED DIABETES SUPPLY	19	2010–2013

Firm	Filings	Years
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ	507	2007–2019

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

Food and Drug Administration Safety Over Sequestration Act of 2013

Cited source text

H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues

Food and Drug Administration Safety Over Sequestration Act of 2013

Cited source text

H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

2019 · second_quarter · Q2

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Competitive bidding.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

2019 · second_quarter · 2T

Firm income: —Client expense: —Open original LDA filing ↗